Atlas Trials

Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy

Clinical trial NCT05202899 · UNKNOWN

Trial details

NCT number
NCT05202899
Sponsor
Guangzhou General Hospital of Guangzhou Military Command
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Brain Tumors
Start date
2020-09-01
Primary completion
2022-02-28
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.